Vertex Pharmaceuticals (NASDAQ:VRTX) Given New $420.00 Price Target at Royal Bank of Canada
Vertex Pharmaceuticals (NASDAQ:VRTX – Free Report) had its target price boosted by Royal Bank of Canada from $408.00 to $420.00 in a research report sent to investors on Tuesday morning,Benzinga ...
Investing Snacks23h
Vertex Vaults: Wall Street’s New Favorite Pill
Bank of America upped its price target for Vertex Pharmaceuticals from $555 to $567, signaling growing confidence in the ...